Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Dunn

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell CarcinomasTenny Mudianto, Katie M Campbell, Jason Webb, et al.
Nature Genetics|November 7, 2018
A deep learning approach to automate refinement of somatic variant calling from cancer sequencing dataBenjamin J Ainscough, Erica K Barnell, Peter Ronning, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1Jason M Law, Sebastian C Stark, Ke Liu, et al.
Nature Communications|November 4, 2021
Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastomaTatenda Mahlokozera, Bhuvic Patel, Hao Chen, et al.
Neuro-Oncology Advances|February 14, 2022
Multivariate analysis of associations between clinical sequencing and outcome in glioblastomaPeter H Yang, Yu Tao, Jingqin Luo, et al.
Neurosurgical Review|March 9, 2026
Neurosurgical leadership in neuro-oncology clinical trials: A nationwide studyChristian K Ramsoomair, Manav Daftari, Akhil Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2024
Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed GlioblastomaTanner M Johanns, Elizabeth A R Garfinkle, Katherine E Miller, et al.
World Neurosurgery|August 26, 2022
Survival After Resection of Newly-Diagnosed Intracranial Grade II Ependymomas: An Initial Multicenter Analysis and the Logistics of Intraoperative Magnetic Resonance ImagingAlexander T Yahanda, Keith M Rich, Ralph G Dacey, et al.
Oncotarget|September 23, 2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumorsYu Mei, Wenya Linda Bi, Noah F Greenwald, et al.
Journal for Immunotherapy of Cancer|February 22, 2023
TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastomaMaximilian O Schaettler, Rupen Desai, Anthony Z Wang, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell CarcinomasTenny Mudianto, Katie M Campbell, Jason Webb, et al.
Nature Genetics|November 7, 2018
A deep learning approach to automate refinement of somatic variant calling from cancer sequencing dataBenjamin J Ainscough, Erica K Barnell, Peter Ronning, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1Jason M Law, Sebastian C Stark, Ke Liu, et al.
Nature Communications|November 4, 2021
Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastomaTatenda Mahlokozera, Bhuvic Patel, Hao Chen, et al.
Neuro-Oncology Advances|February 14, 2022
Multivariate analysis of associations between clinical sequencing and outcome in glioblastomaPeter H Yang, Yu Tao, Jingqin Luo, et al.
Neurosurgical Review|March 9, 2026
Neurosurgical leadership in neuro-oncology clinical trials: A nationwide studyChristian K Ramsoomair, Manav Daftari, Akhil Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2024
Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed GlioblastomaTanner M Johanns, Elizabeth A R Garfinkle, Katherine E Miller, et al.
World Neurosurgery|August 26, 2022
Survival After Resection of Newly-Diagnosed Intracranial Grade II Ependymomas: An Initial Multicenter Analysis and the Logistics of Intraoperative Magnetic Resonance ImagingAlexander T Yahanda, Keith M Rich, Ralph G Dacey, et al.
Oncotarget|September 23, 2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumorsYu Mei, Wenya Linda Bi, Noah F Greenwald, et al.
Journal for Immunotherapy of Cancer|February 22, 2023
TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastomaMaximilian O Schaettler, Rupen Desai, Anthony Z Wang, et al.
Pageof 15